Pappas Ventures
P.O. Box 110287
Research Triangle Park
North Carolina
27709
United States
Tel: 919-998-3300
Fax: 919-998-3301
Website: http://www.pappasventures.com/
Email: info@pappasventures.com
About Pappas Ventures
Pappas Ventures is a Research Triangle Park, North Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has over $350 million under management, and is currently investing out of its fourthventure capital fund. Among the firm’s more than 40 portfolio companies are FlowCardia, LipoScience, Plexxikon, BrainCells, CeNeRx BioPharma , CoLucid Pharmaceuticals, and TyRx. The firm's primary investment focus is on product-oriented biotechnology and pharmaceutical companies, with a secondary focus on medical technologies.4 articles about Pappas Ventures
-
Pappas Capital Expands Leadership Team With Appointments Of Kyle Rasbach To Managing Partner And Matthew Boyer To Chief Financial Officer
7/16/2019
Positions Firm for Next Phase of Growth and Development Following Successful 25-Year Track Record
-
4D Molecular Therapeutics snagged $90 million in a Series B financing round. The company intends to use the funds to advance its Therapeutic Vector Evolution platform and pipeline of next-generation AAV gene therapeutics.
-
Pappas Ventures Promotes Scott Weiner To Partner
1/8/2014
-
Pappas Ventures Release: Art Pappas Elected to NVCA Board of Directors
5/15/2013